Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2026)

Fulgent Genetics has reported Non-Current Deferred Tax Liability for 7 years, with the latest figure at $6.9 million in Q2 2026.

• Quarterly Non-Current Deferred Tax Liability rose 12.54% year-over-year to $6.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.9 million (up 12.54% YoY) and the FY2025 annual result came in at $6.9 million, up 8.89% from the prior year.
• Non-Current Deferred Tax Liability eased to $6.9 million in Q2 2026 per FLGT's latest filing, from $7.0 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $9.8 million in Q3 2023 and troughed at $6.1 million in Q2 2025.
• A 4-year average of $7.1 million and a median of $6.9 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2024 and 2026: Non-Current Deferred Tax Liability tumbled 31.52% in 2024, then advanced 12.54% in 2026.
• Over 4 years, Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then slipped by 19.99% to $6.4 million in 2024, then grew by 8.89% to $6.9 million in 2025, then slipped by 0.63% to $6.9 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.9 million, $7.0 million, and $6.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.